Nitrendipin Aristo (Nitrendipine)

Nitrendipine blocks L‑type calcium channels on vascular smooth‑muscle cells, preventing calcium entry that drives contraction. This causes arterial vasodilation, reduces peripheral vascular resistance, and lowers systemic blood pressure while also decreasing the workload on the heart, which alleviates anginal symptoms.

The specific dose of Nitrendipin Aristo is determined by the prescribing clinician based on the individual’s clinical condition, response to therapy, and any concomitant medications. Physicians typically start with a low dose and titrate upward as needed, following local prescribing guidelines.

Safety data for nitrendipine during pregnancy and lactation are limited. It should only be used when the potential therapeutic benefit justifies the possible risk to the fetus or infant. Healthcare providers must evaluate each case individually and discuss risks with the patient.

To request Nitrendipin Aristo, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements if applicable), and necessary import documentation.

Nitrendipine belongs to the dihydropyridine class of calcium channel blockers, offering potent arterial vasodilation with a relatively low effect on heart rate. Compared with agents such as amlodipine, it has a similar efficacy profile but may differ in pharmacokinetic properties and side‑effect frequency, making individual patient factors important when selecting therapy.

Store the product at ambient temperature below 25 °C, in its original packaging, protected from moisture and direct light. Keep the container tightly closed and out of reach of children. Do not store in a refrigerator or freezer unless the label explicitly states otherwise.

Nitrendipin Aristo is taken orally, usually with a glass of water. It can be administered with or without food, but consistent intake with respect to meals helps maintain stable plasma levels. Patients should follow the dosing schedule prescribed by their healthcare professional.

The most serious adverse events include severe hypotension, myocardial infarction, cardiac arrhythmias, and rare but severe skin reactions such as Stevens‑Johnson syndrome. Patients should be instructed to seek immediate medical attention if they experience sudden dizziness, fainting, chest pain, or any signs of an allergic reaction.

Nitrendipin Aristo is contraindicated in patients with known hypersensitivity to nitrendipine or other dihydropyridine calcium channel blockers, those experiencing severe hypotension, cardiogenic shock, or acute myocardial infarction. Caution is also advised in patients with significant hepatic impairment or uncontrolled heart failure.